H1Bh1bdatabase.info

Employer profile

Syndax Pharmaceuticals

2 certified H-1B filings across 2 fiscal years.

Snapshot year
FY2023 filings
1
FY2023 median
$180k
Top role
Director, Clinical Research And Development
1 filings · all-time
Top state
MA
2 filings · all-time

Pay distribution

How Syndax Pharmaceuticals pays, by fiscal year

Each box is the p25–p75 interquartile range; the heavy line is the median and the whiskers reach p10–p90. Base salary only — hover a year for its figures.

$160k$180k$200k$220k$240k$260k1723

Year-over-year

How Syndax Pharmaceuticals hired across H-1B fiscal years. The small figure under each filings count is its change vs the prior FY.

FYFilingsMedian $
FY202310%$180k
FY20171$250k

Prevailing wage level distribution

DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.

Lvl IV
2100%

Top job titles

Most-filed positions, across all years (raw DOL titles).

Job TitleFilingsMedian
Director, Clinical Research And Development1$250k
Principal Statistical Programmer1$180k

Top worksite states

Where this employer files.

StateFilingsMedian
MA2$180k
Browse all 2 filings →Just FY2023

Related employers

Browse all sponsors →

Frequently asked questions

How much does Syndax Pharmaceuticals pay H-1B workers?
Syndax Pharmaceuticals's median certified H-1B base salary is $180k (FY2023), from 1 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Syndax Pharmaceuticals sponsor?
Syndax Pharmaceuticals has 2 certified H-1B Labor Condition Applications on record (FY2017–FY2023).
What jobs does Syndax Pharmaceuticals sponsor for H-1B?
Syndax Pharmaceuticals's most-sponsored H-1B roles include Director, Clinical Research And Development, Principal Statistical Programmer.
Where does Syndax Pharmaceuticals hire H-1B workers?
Syndax Pharmaceuticals's top H-1B worksite states are MA.

Calculate your H-1B lottery odds →orCheck out the insights →